Phase I and pharmacokinetic study of elacytarabine, a novel 5-elaidic acid derivative of cytarabine, in adults with refractory hematological malignancies.

Francis Joseph Giles

doi:10.1038/leu.2012.1

Phase I and pharmacokinetic study of elacytarabine, a novel 5-elaidic acid derivative of cytarabine, in adults with refractory hematological malignancies.

Francis Joseph Giles

Medicine

Research output: Contribution to a Journal (Peer & Non Peer) › Article › peer-review

20 Citations (Scopus)

Original language	English (Ireland)
Pages (from-to)	1686-1689
Number of pages	4
Journal	Leukemia : official journal of the Leukemia Society of America, Leukemia Research Fund, U.K
Volume	26
Issue number	7
DOIs	https://doi.org/10.1038/leu.2012.1
Publication status	Published - 1 Jul 2012

Authors (Note for portal: view the doc link for the full list of authors)

Authors
Giles FJ, Vey N, Rizzieri D, Ravandi F, Prebet T, Borthakur G, Jacobsen TF, Hagen S, Nilsson B, O'Brien S

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

Access to Document

10.1038/leu.2012.1

Cite this

@article{e581bdf4373446c89a25d98686ac754e,

title = "Phase I and pharmacokinetic study of elacytarabine, a novel 5-elaidic acid derivative of cytarabine, in adults with refractory hematological malignancies.",

author = "Giles, \{Francis Joseph\}",

year = "2012",

month = jul,

day = "1",

doi = "10.1038/leu.2012.1",

language = "English (Ireland)",

volume = "26",

pages = "1686--1689",

journal = "Leukemia : official journal of the Leukemia Society of America, Leukemia Research Fund, U.K",

number = "7",

}

Phase I and pharmacokinetic study of elacytarabine, a novel 5-elaidic acid derivative of cytarabine, in adults with refractory hematological malignancies. / Giles, Francis Joseph.
In: Leukemia : official journal of the Leukemia Society of America, Leukemia Research Fund, U.K, Vol. 26, No. 7, 01.07.2012, p. 1686-1689.

Research output: Contribution to a Journal (Peer & Non Peer) › Article › peer-review

TY - JOUR

T1 - Phase I and pharmacokinetic study of elacytarabine, a novel 5-elaidic acid derivative of cytarabine, in adults with refractory hematological malignancies.

AU - Giles, Francis Joseph

PY - 2012/7/1

Y1 - 2012/7/1

UR - https://www.scopus.com/pages/publications/84863779790

U2 - 10.1038/leu.2012.1

DO - 10.1038/leu.2012.1

M3 - Article

VL - 26

SP - 1686

EP - 1689

JO - Leukemia : official journal of the Leukemia Society of America, Leukemia Research Fund, U.K

JF - Leukemia : official journal of the Leukemia Society of America, Leukemia Research Fund, U.K

IS - 7

ER -

Phase I and pharmacokinetic study of elacytarabine, a novel 5-elaidic acid derivative of cytarabine, in adults with refractory hematological malignancies.

Authors (Note for portal: view the doc link for the full list of authors)

UN SDGs

Access to Document

Other files and links

Cite this